Graduate Trainee
Croda, Inc.
Dr. Qiaobin Hu serves as a Graduate Trainee within the Pharma R&D Team at Croda Inc., with over nine years of expertise in nanoparticle delivery systems for nucleic acids and small molecules. He plays an important role in advancing the cutting-edge pharma platform, using his expertise to optimize the preparation and characterization of lipid nanoparticles (LNPs) formulations and to explore innovative therapeutics. Prior to joining Croda Pharma in 2023, he dedicated nine years to developing biodegradable and biocompatible nano-delivery systems using biomacromolecules, including polysaccharides, proteins, and lipids, for the targeted delivery of natural small molecules in the fight against chronic diseases, such as obesity.
Dr. Hu's contributions extend beyond the laboratory, with a notable presence in academia. He has authored a book chapter and published over 35 high-quality articles in peer-reviewed scientific journals in the field of nutritional science and related areas. His work has garnered significant recognition, accumulating more than 2800 citations from peer researchers across numerous countries and territories worldwide.